Walleye Capital
NAMS icon

Walleye Capital’s NewAmsterdam Pharma NAMS Stock Holding History

Walleye Capital’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.79M Buy
111,819
+53,385
+91% +$1.76M 0.01% 1003
2026
Q1 		$1.87M Sell
58,434
-37,827
-39% -$1.23M 0.01% 1523
2025
Q4 		$3.38M Buy
+96,261
New +$3.5M 0.01% 1452
2025
Q1 		– Sell
-10,506
Closed -$270K – 4818
2024
Q4 		$270K Sell
10,506
-36,441
-78% -$774K ﹤0.01% 3518
2024
Q3 		$779K Buy
+46,947
New +$812K ﹤0.01% 2888

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

Walleye Capital's NAMS Position: Q2 2026 in Review

Walleye Capital increased its NewAmsterdam Pharma (NAMS) stake by 91% in Q2 2026, buying an estimated $1.76M and bringing the position to 111,819 shares worth $3.79M. The position accounts for 0.01% of the portfolio, ranked #1003.

Walleye Capital first reported a position in NAMS in Q3 2024 and has held it in 5 quarters since. 195 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • Walleye Capital held 111,819 shares of NewAmsterdam Pharma worth $3.79M as of Q2 2026.
  • Walleye Capital bought 53,385 NewAmsterdam Pharma shares in Q2 2026, an estimated $1.76M.
  • NewAmsterdam Pharma made up 0.01% of Walleye Capital's portfolio in Q2 2026, its #1003 holding.
  • Walleye Capital first reported a position in NewAmsterdam Pharma in Q3 2024 and has held it in 5 quarters since.
  • 195 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.